Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

PROCEPT BioRobotics (PRCT) Enterprise Value (2020 - 2025)

PROCEPT BioRobotics (PRCT) has disclosed Enterprise Value for 6 consecutive years, with -$286.5 million as the latest value for Q4 2025.

  • On a quarterly basis, Enterprise Value rose 14.15% to -$286.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$286.5 million, a 14.15% increase, with the full-year FY2025 number at -$286.5 million, up 14.15% from a year prior.
  • Enterprise Value was -$286.5 million for Q4 2025 at PROCEPT BioRobotics, up from -$294.3 million in the prior quarter.
  • In the past five years, Enterprise Value ranged from a high of -$86.1 million in Q1 2021 to a low of -$333.7 million in Q4 2024.
  • A 5-year average of -$247.2 million and a median of -$263.5 million in 2022 define the central range for Enterprise Value.
  • Peak YoY movement for Enterprise Value: tumbled 230.11% in 2022, then skyrocketed 44.23% in 2023.
  • PROCEPT BioRobotics' Enterprise Value stood at -$304.3 million in 2021, then grew by 26.84% to -$222.6 million in 2022, then dropped by 15.53% to -$257.2 million in 2023, then fell by 29.74% to -$333.7 million in 2024, then increased by 14.15% to -$286.5 million in 2025.
  • Per Business Quant, the three most recent readings for PRCT's Enterprise Value are -$286.5 million (Q4 2025), -$294.3 million (Q3 2025), and -$302.7 million (Q2 2025).